HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling by Tsung, Allan et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
ARTICLE
JEM © The Rockefeller University Press  $30.00
Vol. 204, No. 12,  November 26, 2007  2913-2923  www.jem.org/cgi/doi/
2913
10.1084/jem.20070247
        Activation of the innate immune system has long 
been recognized as a necessary step in mounting 
an antimicrobial response to pathogens. Sterile 
infl  ammatory insults initiated by trauma or isch-
emia activate many of the same innate immune 
signaling pathways. At the molecular level, these 
observations may be explained, at least in part, by 
the capacity of both pathogen-associated molec-
ular pattern molecules and damage-associated 
molecular pattern (DAMP) molecules to activate 
cell signaling through common pattern recog-
nition receptors of the innate immune system. 
DAMPs can be classifi  ed as normal cell constitu-
ents released by damaged or dying cells, or com-
ponents of the extracellular matrix released by 
the action of proteases at the site of tissue damage. 
For example, Toll-like receptor (TLR) 4 signal-
ing can be activated by cell constituents such as 
high-mobility group box 1 (HMGB1) (  1, 2  ), heat 
shock proteins (  3  ), or uric acid crystals (  4  ) or the 
matrix component heparin sulfate (  5  ). 
  TLR proteins are pattern recognition recep-
tors composed of 13 family members in mice 
and 10 in humans. Members of the TLR family 
have many structural similarities, both extracel-
lularly and intracellularly, but they diff  er from 
each other in ligand specifi  city, expression pat-
terns, and in some instances the signaling path-
ways they activate. TLR4 is one of a subset of 
pattern recognition receptors that recognize 
both DAMPs and pathogen-associated molecular 
patterns and, hence, is involved in immune re-
sponse to both infection and injury. TLR4 was 
fi  rst characterized as part of the bacterial endo-
toxin recognition complex (  6  ). More recently, 
the role of TLR4 in ischemia/reperfusion (I/R) 
injury has been revealed in studies in mice show-
ing that the lack of TLR4 or impairment of 
TLR4 signaling results in less tissue damage and 
an attenuated infl  ammatory response in hepatic 
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  Ischemic tissues require mechanisms to alert the immune system of impending cell damage. 
The nuclear protein high-mobility group box 1 (HMGB1) can activate infl  ammatory path-
ways when released from ischemic cells. We elucidate the mechanism by which HMGB1, 
one of the key alarm molecules released during liver ischemia/reperfusion (I/R), is mobilized 
in response to hypoxia. HMGB1 release from cultured hepatocytes was found to be 
an active process regulated by reactive oxygen species (ROS). Optimal production of ROS 
and subsequent HMGB1 release by hypoxic hepatocytes required intact Toll-like receptor 
(TLR) 4 signaling. To elucidate the downstream signaling pathways involved in hypoxia-
induced HMGB1 release from hepatocytes, we examined the role of calcium signaling in this 
process. HMGB1 release induced by oxidative stress was markedly reduced by inhibition 
of calcium/calmodulin-dependent kinases (CaMKs), a family of proteins involved in a wide 
range of calcium-linked signaling events. In addition, CaMK inhibition substantially de-
creased liver damage after I/R and resulted in accumulation of HMGB1 in the cytoplasm of 
hepatocytes. Collectively, these results demonstrate that hypoxia-induced HMGB1 release 
by hepatocytes is an active, regulated process that occurs through a mechanism promoted 
by TLR4-dependent ROS production and downstream CaMK-mediated signaling. 2914 HYPOXIA-INDUCED HMGB1 RELEASE IN HEPATOCYTES | Tsung et al.
not substantially diff  erent between cells exposed to hypoxia or 
H  2  O  2   compared with control cells (unpublished data). To fur-
ther confi  rm whether diff  erences found with HMGB1 release 
may refl  ect diff  erences in cell death, actin levels in the superna-
tants of cells exposed to hypoxia or normoxia were also shown to 
be similar (  Fig. 1 E  ). These results suggest that oxidant-induced 
(  2, 7  ), renal (  8, 9  ), and cardiac (  8  ) I/R, as well as hemorrhagic 
shock (  10, 11  ). We have provided evidence that HMGB1 is 
essential to TLR4 signaling in hepatic I/R (  2  ) and hemor-
rhagic shock (  11, 12  ), whereas others have provided evi-
dence for direct interaction of HMGB1 with the TLR4 receptor 
complex in vitro (  1, 13  ). 
  HMGB1 is an evolutionarily conserved protein present in 
the nucleus of almost all eukaryotic cells, where it functions to 
stabilize nucleosomes and acts as a transcription factor (  14, 15  ). 
Its proinfl  ammatory properties were identifi  ed in experiments 
showing that HMGB1 is actively secreted by activated macro-
phages and that HMGB1 is a late mediator of lethality in sepsis 
models (  16, 17  ). Although HMGB1 can also be released by 
cells undergoing necrosis (  18, 19  ), the actions of HMGB1 in 
I/R occur before cell death, suggesting that HMGB1 is mo-
bilized and released in response to hypoxia. In this paper, we 
show that hypoxia-induced HMGB1 release by hepatocytes 
occurs through a mechanism promoted by TLR4-dependent 
reactive oxygen species (ROS) production and downstream 
calcium/calmodulin-dependent kinase (CaMK)  –  mediated 
signaling. We also show that these signaling pathways are in-
volved in I/R-induced injury and infl  ammation in the liver 
in vivo. Thus, TLR4 participates not only in the recognition of 
HMGB1 but also in its release through a mechanism involving 
ROS production and CaMK activation. These fi  ndings provide 
a mechanism by which ischemic tissues notify the immune 
system of the potential loss of tissue integrity. 
    RESULTS   
  Oxidative stress induces HMGB1 release from hepatocytes 
  We have previously shown that HMGB1 is a proximal mediator 
of infl  ammation and injury induced by I/R in the liver (  20  ). 
Our observation that hypoxia leads to HMGB1 release by 
hepatocytes in the absence of cell death suggests that HMGB1 
mobilization in these cells is a regulated process. To deter-
mine if ROS produced during hypoxia contributes to hypoxia-
induced HMGB1 release, hepatocytes were cultured under 
normoxic (21% oxygen) or hypoxic (1% oxygen) conditions and 
in the presence or absence of the antioxidant   N  -acetylcysteine 
(NAC). Hypoxia led to a time-dependent increase in HMGB1 
release into the media (Fig. 1 A).   This release was prevented 
by NAC. To further establish the role of ROS in the mecha-
nism of HMGB1 release, hepatocytes were treated with H  2  O  2   
in concentrations from 125 to 500      M. HMGB1 levels in the 
media were found to increase in a concentration-dependent 
manner at 8 h after H  2  O  2   exposure (  Fig. 1 B  ). Treatment with 
the antioxidants NAC or Trolox abrogated the H  2  O  2  -mediated 
HMGB1 release (  Fig. 1 C  ). 
  It is known that HMGB1 can be released from cells by either 
an active, regulated, process or passively released during cell 
necrosis. Previous work has shown that hypoxia alone leads to 
minimal hepatocyte death in vitro in the fi  rst 18  –  24 h (  21, 22  ). 
Cell viability was not substantially diff  erent between hepatocytes 
exposed to hypoxia or normoxia or upon stimulation with 
H  2  O  2   at concentrations up to 500      M with a crystal violet via-
bility assay (  Fig. 1 D  ). Lactate dehydrogenase levels were also 
  Figure 1.     Oxidative stress induces HMGB1 release from hepato-
cytes. (A) Western blot analysis of supernatants from hepatocytes that 
underwent 8, 12, or 24 h of hypoxia (1% O  2  ). Cells were plated in Williams  ’   
medium E or Williams  ’   medium E containing 50 mM NAC. The blot 
shown is representative of three different experiments with similar re-
sults. (B) Hepatocytes were stimulated with 125, 250, or 500     M  H 2 O 2   for 
8 h, and supernatants were sampled and subjected to Western blot analy-
sis for HMGB1. The blot shown is representative of three different experi-
ments with similar results. (C) Hepatocytes were exposed to 500     M  H 2 O 2  
for 30 min before treatment with NAC or Trolox in a dose  –  response fash-
ion. Supernatants were sampled at 8 h and subjected to Western blot 
analysis for HMGB1. The blot shown is representative of three different 
experiments with similar results. (D) Viability was determined by crystal 
violet assay on hepatocytes subjected to either 24 h of hypoxia (1% O  2 )  or 
8 h of oxidative stress from H  2 O 2  . Results are expressed as the mean   ±   
SEM. (E) Hepatocytes were exposed to normoxia (N) or hypoxia (H) for 
8 and 24 h, and supernatants were sampled for Western blot analysis for 
HMGB1. The blot shown is representative of multiple experiments with 
similar  results.   JEM VOL. 204, November 26, 2007 
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HMGB1 release from hepatocytes is not mainly caused by cell 
death and is likely to be an active process regulated by ROS. 
  HMGB1 release from hepatocytes under oxidative stress 
is calcium dependent 
  To elucidate the downstream signaling pathways involved in 
hypoxia-induced HMGB1 release from hepatocytes, we ex-
amined the role of calcium signaling in this process. It is known 
that intracellular calcium is released after oxidative stress, lead-
ing to the activation of calcium-dependent signaling pathways 
(  23, 24  ). Increasing intracellular levels of calcium with the 
calcium ionophore A23187 resulted in the release of HMGB1 
from resting hepatocytes (  Fig. 2 A  ).   HMGB1 release induced 
by either H  2  O  2   exposure or hypoxia was markedly reduced 
by treatment with the calcium chelator bapta (  Fig. 2 A  ). Because 
a wide range of calcium-linked signaling events are mediated by 
a family of CaMKs, we asked if these enzymes were involved 
in HMGB1 release. The CaMK inhibitor KN62 markedly 
inhibited both hypoxia- and H  2  O  2  -induced HMGB1 release 
(  Fig. 2 A  ). We confi  rmed that hepatocytes express CaMK us-
ing RT-PCR (  Fig. 2 B  ). Isoforms I, II     , and IV were detected 
at the messenger RNA (mRNA) level. The eff  ect of calcium 
modulation on HMGB1 release was not caused by cell death 
because cell viability was not substantially diff  erent among the 
diff  erent treatment groups (  Fig. 2 C  ). These results suggest 
that HMGB1 release by ischemic hepatocytes is regulated 
by calcium-mediated signaling involving the CaMK cascade. 
To further elucidate the specifi  c CaMK isotypes involved in 
oxidant-mediated HMGB1 release, small interfering RNA 
(siRNA) technology was used to complement the pharmaco-
logic inhibitor experiments. Hepatocytes were transfected with 
siRNA to the various isotypes of CaMKs (I, II     , and IV) and 
their upstream activators, CaMK kinases (CaMKKs)       and       
(  25  ). The specifi  city of the various CaMK siRNAs were de-
termined by Western blotting (knockdown of CaMKK       was 
determined by RT-PCR, as there is no commercially avail-
able antibody to this protein;   Fig. 2 D  ). The cells were stimu-
lated with H  2  O  2  , and their release of HMGB1 was examined 
(  Fig. 2 E  ). We found that CaMK IV and the CaMKK       appear 
to be involved in oxidant stress  –  mediated HMGB1 release 
in hepatocytes. 
  CaMK inhibition protects against liver I/R injury 
  Our laboratory has recently shown that HMGB1 is an early 
mediator of injury and infl  ammation in liver I/R (  2  ). Because 
HMGB1 release from hepatocytes under oxidative stress was 
mediated in part by CaMKs, we asked if CaMK-dependent 
signaling played a role in vivo during liver I/R. Animals were 
given KN93, an inhibitor of CaMK activity, or KN92, an 
inactive analogue of KN93, 12 and 1 h before ischemia. 
  Figure 2.     HMGB1 release from hepatocytes under oxidative stress 
is calcium dependent. (A) Hepatocytes were treated with A23187 (calcium 
ionophore), bapta (calcium chelator), or KN62 (CaMK inhibitor) for 30 min 
to alter intracellular calcium signaling. Cells were then exposed to 500     M 
H  2 O 2   for 8 h or to hypoxia (1% O  2  ) for 24 h. Supernatants were sampled 
and subjected to Western blot analysis for HMGB1. The blot shown is rep-
resentative of three different experiments with similar results. (B) CaMK 
mRNA expression levels in rat primary hepatocytes (lane 1) were detected 
by RT-PCR using specifi  c primers for CaMK I, II    ,  II   ,  II   ,  II    , and IV, re-
spectively. Rat cerebral cortex extract (lane 2) was used as a positive con-
trol. (C) Plated cells from the experiment in A underwent assessment of 
cell viability by crystal violet assay after supernatant samples had been 
taken. Results are expressed as the mean   ±   SEM. The experiment shown 
is representative of three different experiments with similar results. 
(D) Hepatocytes were transfected with siRNA to each CaMK (I, II     , and IV) or 
the upstream CaMKK (CaMKK       and CaMKK      2). The specifi  city of each 
siRNA was confi  rmed by Western blot (CaMK I, CaMK IV, CaMKK     2,  and 
CaMK II     ,) or RT-PCR (CaMKK      ). (E) HMGB1 release was examined in the 
transfected cells stimulated with or without H  2 O 2  . The experiment shown 
is representative of three different experiments with similar results.     
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from mice treated with control KN92, whereas minimal dam-
age was noted in samples from KN93-treated mice (not 
depicted). To determine if CaMK inhibition aff  ected HMGB1 
release during liver I/R, serum HMGB1 levels of mice treated 
with KN93 and control KN92 were examined using Western 
blotting. Circulating HMGB1 was increased in control KN92-
treated mice compared with sham-treated animals at 6 h after 
Serum alanine aminotransferase (sALT) levels were used to 
estimate the magnitude of liver damage. We found that KN92 
did not alter the level of injury in mice subjected to I/R. 
Treatment with KN93 resulted in signifi  cant protection 
from hepatic injury (  Fig. 3 A  ).   Histologic analysis confi  rmed 
the sALT estimation of liver damage. Severe sinusoidal con-
gestion and hepatocellular necrosis were present in liver tissue 
  Figure 3.     CaMK inhibition protects against liver I/R injury. (A) Mice were given 16-mg/kg intraperitoneal injections of KN93, a CaMK inhibitor, 
or KN92, an inactive analogue, 12 and 1 h before ischemia. Mice underwent 1 h of ischemia and 6 h of reperfusion before serum samples were taken and 
tested for ALT levels. Sham animals that were injected with the same solutions were subjected only to laparotomy without ischemia. Data represent 
means   ±   SE (  n   = 6  –  10 animals). *,P   <   0.05 versus mice subjected to I/R and treated with KN92 control. (B) Western blot analysis for HMGB1 was also performed 
on serum samples from animals. Each lane represents a different animal. The blot shown is representative of two experiments with similar results. 
(C) Immunofl  uorescent stain of HMGB1 from sections of livers subjected to sham operation or 60 min of ischemia and 6 h of reperfusion. Mice were given 
intraperitoneal injections of KN93, a CaMK inhibitor, or KN92, an inactive analogue, 12 and 1 h before ischemia. Images are representative liver sections 
from six mice per group (green, HMGB1; blue, nuclei; red, F-actin). Bars: (  ×  200) 50     m;  ( × 800)  10     m.   JEM VOL. 204, November 26, 2007 
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reperfusion (  Fig. 3 B  ). Serum HMGB1 levels were markedly 
lower after I/R in the KN93-pretreated mice. To determine the 
eff  ect of CaMK inhibition on the cellular localization of HMGB1 
in the liver, immunofl  uorescence staining was performed. 
Consistent with our previous observations (  2  ), HMGB1 was 
almost exclusively localized in the nucleus of hepatocytes in 
the livers of sham-treated mice (  Fig. 3 C  ). There was no con-
siderable diff  erence in HMGB1 staining between sham animals 
treated with KN93 or the control compound KN92. After I/R, 
the intensity of HMGB1 staining increased in some hepato-
cytes, whereas others were depleted of HMGB1 in the control 
KN92-treated group. In livers of mice pretreated with KN93 
before I/R, there was a clear accumulation of HMGB1 in the 
cytoplasm of hepatocytes compared with the livers of mice 
pretreated with control KN92 before I/R. These fi  ndings 
suggest that the protective eff  ect of CaMK inhibition against 
liver I/R may be in part caused by the prevention of HMGB1 
release from hepatocytes. 
  Functional TLR4 signaling required for optimal ROS 
production and HMGB1 release from hepatocytes during 
oxidative stress 
  TLR4 signaling is involved in I/R-induced infl  ammation and 
injury. We have provided evidence that HMGB1 stimulates 
TLR4 signaling in I/R in the liver (  2, 20  ); however, it is un-
known whether TLR4 participates in hypoxia-induced ROS 
production and HMGB1 release. We initially assessed this 
in vitro using cultured hepatocytes. Wild-type hepatocytes ex-
posed to hypoxia produced ROS over time, as measured by 
2     ,7     -dichlorofl  uorescein (DCF) fl  uorescence compared with 
normoxia (  Fig. 4 A  ).   An assay to measure two markers of lipid 
peroxidation, malondialdehyde (MDA) and 4-hydroxyalkenal 
(4-HAE), was also used as an estimate of oxidant production to 
demonstrate that hypoxia resulted in ROS generation (  Fig. 4 B  ). 
In contrast to wild-type hepatocytes, TLR4 KO hepatocytes 
generated signifi  cantly lower levels of ROS compared with the 
wild-type counterparts (  Fig. 4 A  ). To confi  rm that functional 
TLR4 signaling was involved in ROS production in hepato-
cytes during hypoxia, TLR4 KO hepatocytes were transfected 
with empty adenoviral vector control (Ad-null) or recombinant 
adenovirus encoding TLR4 (Ad-TLR4). Transfection of TLR4 
KO hepatocytes with Ad-null resulted in lower ROS produc-
tion during hypoxia (30 min) compared with wild-type levels 
(  Fig. 4 C  ). However, transfection of TLR4 KO hepatocytes with 
Ad-TLR4 increased ROS production during hypoxia to levels 
comparable to TLR4 wild type. Our previous experiments have 
suggested that HMGB1 may be a ligand for TLR4 ( 2  ). The mecha-
nism of TLR4-dependent ROS production did not involve 
an HMGB1  –  TLR4 interaction because blockade of HMGB1 
did not aff  ect hypoxia-induced ROS production (  Fig. 4 D  ). 
  Figure 4.     Functional TLR4 signaling required for optimal ROS 
production. (A) Hepatocytes from TLR4 wild-type and KO mice were plated 
and incubated with 10   μ  M DCF-DA for 30 min before treatment. Cells 
were subjected to normoxia or hypoxia (1% O  2  ) for times up to 50 min, 
and ROS production was measured by fl  uorescence spectrophotometry. 
Data represent means   ±   SE. *, P   <   0.05 versus TLR4 KO hepatocytes sub-
jected to hypoxia. (B) Hepatocytes plated in 10-cm plates were exposed 
to either normoxia or hypoxia for 2 h. Baseline samples, in addition to 2-h 
samples, were assayed for byproducts of lipid peroxidation, MDA and 
4-HAE. *, P   <   0.05 versus 2-h normoxic controls. (C) Hepatocytes from TLR4 
wild-type and KO mice were transfected with adenoviral vector encoding 
either murine TLR4 (Ad-TLR4) or empty adenoviral vector control (Ad-null). 
Cells were subjected to 30 min of hypoxia. ROS production measured by 
DCF assay shown is the percent increase relative to respective normoxic 
controls. *, P   <   0.05 versus TLR4 wild-type controls treated with Ad-null 
virus. (D) Hepatocytes were treated with either anti-HMGB1 neutralizing 
 
antibody or IgG control and exposed to normoxia or hypoxia (1% O  2 )  for 
30 min. ROS production was measured by DCF assay, and results are 
reported as the percentage relative to normoxic controls. Results in B  –  D 
are expressed as the mean   ±   SEM.     2918 HYPOXIA-INDUCED HMGB1 RELEASE IN HEPATOCYTES | Tsung et al.
Furthermore, a supernatant from hypoxic cells trans  ferred to 
normoxic cells did not trigger HMGB1 release (unpublished data), 
suggesting that a soluble factor is not involved. 
  To determine the role of TLR4 signaling in HMGB1 re-
lease in response to oxidant stress, TLR4 wild-type and KO 
hepatocytes were exposed to hypoxia. Both TLR4 wild-type 
and TLR4 KO hepatocytes exhibited a time-dependent in-
crease in HMGB1 release during hypoxia (  Fig. 5 A  ).   However, 
the release of HMGB1 from TLR4 KO hepatocytes was 
markedly less. TLR4 viral transfection enhanced hypoxia-
induced HMGB1 release in TLR4 KO and, to a lesser extent, 
in TLR4 wild-type cells ( Fig. 5 B ). The overexpression of TLR4 
by transfection in both KO and wild-type hepatocytes was 
confi  rmed by Western blotting for TLR4 (not depicted). 
Although the hypoxic-induced HMGB1 release in the TLR4 
KO hepatocytes was less than in wild-type cells, the release 
observed in these cells was still dependent on calcium, CamK, 
and ROS (  Fig. 5, C and D  ). The diff  erences in HMGB1 release 
in TLR4 KO hepatocytes was not caused by baseline diff  erences 
in HMGB1 levels between hepatocytes from the two strains 
of mice because both wild-type and KO hepatocytes contained 
similar levels of HMGB1 (  Fig. 5 E  ). Additionally, treatment 
with H  2  O  2   resulted in similar levels of HMGB1 release in 
both TLR4 wild-type and KO hepatocytes (  Fig. 5 F  ). These 
observations indicate that intact TLR4 signaling promotes 
ROS production and HMGB1 release by hypoxic hepatocytes. 
  Antioxidant-mediated hepatic protection during I/R 
is TLR4 dependent 
  We next sought to determine if functional TLR4 was required 
for ROS-mediated I/R injury in the liver. TLR4 mutant 
(C3H/HeJ) and wild-type control (C3H/HeOuJ) mice were 
subjected to liver I/R mice and were treated with NAC. 
As we (  2  ) and others (  7  ) have previously shown, TLR4 mutant 
mice exhibit less hepatic injury after I/R compared with the 
wild-type mice. NAC reduced the injury in wild-type mice to 
the level observed in TLR4 mutant mice but failed to reduce 
the injury in the TLR4 mutant mice (  Fig. 6 A  ).   Histologic 
evaluation demonstrated severe sinusoidal congestion and 
hepatocellular necrosis in livers from wild-type mice treated 
with saline, whereas minimal damage was noted in liver sec-
tions from NAC-treated mice or the treated or control 
TLR4 mutant groups (not depicted). Similar fi  ndings were 
observed when the antioxidant superoxide dismutase was used 
(unpublished data). As an estimate of oxidant production, 
we measured the formation of MDA and 4-HAE, markers 
of ROS-mediated lipid peroxidation, in wild-type and TLR4 
mutant mice at 1 h after reperfusion. Changes in lipid peroxi-
dation were found to parallel hepatocellular injury. Although 
treatment of wild-type mice with NAC resulted in decreased 
hepatic lipid peroxidation, antioxidant treatment did not fur-
ther reduce the already lower levels of lipid peroxidation in the 
TLR4 mutant mice (  Fig. 6 B  ). Infl  ammatory cytokines, such 
as TNF and IL-6, have been shown to play key roles in the 
pathophysiology of hepatic I/R injury (  26, 27  ). Using real-
time RT-PCR, we measured steady-state mRNA levels for 
  Figure 5.     Functional TLR4 signaling required for HMGB1 release 
from hepatocytes during oxidative stress. (A) TLR4 wild-type and KO 
hepatocytes were plated and subjected to hypoxic (1% O  2 )  conditions 
for various times up to 24 h. The supernatants were sampled at pre-
determined time points and subjected to Western blot analysis for 
HMGB1. The blot shown is representative of three different experiments 
with similar results. (B) Supernatants from   Fig. 4 C   were sampled at 24 h 
and subjected to Western blot analysis for HMGB1. The blot shown is a 
representative blot from multiple experiments. (C) TLR4 wild-type and 
KO hepatocytes were treated with A23187, KN62, or bapta and sub-
jected to normoxia or hypoxia (1% O  2  ). Supernatants were sampled at 
24 h and subjected to Western blot analysis for HMGB1. The blot shown 
is representative of three different experiments with similar results. 
(D) TLR4 wild-type and KO hepatocytes were subjected to hypoxia (1% O  2 ) 
with or without 50-mM NAC treatment. Supernatant was sampled at 
24 h and subjected to Western blot analysis for HMGB1. The blot shown 
is representative of three different experiments with similar results. 
(E) Baseline intracellular HMGB1 levels were determined in TLR4 wild-
type and KO hepatocytes.      -actin was used as a loading control. 
(F) H  2 O 2   was used to stimulate TLR4 wild-type and KO hepatocytes to 
release HMGB1. Cells were subjected to 250 or 500     M  H 2 O 2   for 8 h, 
and supernatants were subjected to Western blot analysis for HMGB1. 
The blot shown is representative of three different experiments with 
similar  results.   JEM VOL. 204, November 26, 2007 
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tissue integrity. Cells of the innate immune system are activated 
after ischemic injury to initiate tissue repair processes and to 
provide defense against microbial invasion. Excessive activation 
can lead to exaggerated local and systemic infl  ammation that 
may extend the tissue damage. In this study, we sought to de-
termine how one of the key alarm molecules released during 
liver I/R, HMGB1, was mobilized in response to hypoxia. 
We show that hypoxic hepatocytes release HMGB1 through 
an active process facilitated by TLR4-dependent ROS pro-
duction. ROS, in turn, induce HMGB1 release through a 
CaMK-dependent mechanism. That these events may be im-
portant in vivo was shown by experiments in a mouse liver I/R 
model in which both CaMK inhibitors and antioxidants re-
duce HMGB1 release and liver damage to the level seen in 
mice defi  cient in TLR4 signaling. 
  HMGB1 is becoming increasingly recognized as the 
prototypic alarmin (  28  ). Initially identifi  ed as a chromatin-
binding protein in the nucleus, its cytokine-like properties were 
revealed in experiments showing that HMGB1 is released by 
activated macrophages and that it acts as a late mediator of 
these cytokines in the liver after I/R. NAC treatment inhib-
ited the expression of TNF and IL-6 mRNA to the levels seen 
in TLR4 mutant mice after I/R (  Fig. 6 C  ). Again, NAC had 
no eff  ect on cytokine mRNA levels in the TLR4 mutant mice 
subjected to I/R. 
  To determine if antioxidant treatment aff  ected HMGB1 
release during liver I/R in TLR wild-type or mutant mice, 
serum HMGB1 levels of animals treated with NAC or control 
saline were examined at 6 h after reperfusion using Western 
blotting. Circulating HMGB1 levels were increased in the 
control saline-treated mice over sham animals (  Fig. 6 D  ). NAC 
treatment prevented this increase. HMGB1 levels increased 
minimally in TLR4 mutant mice subjected to I/R. These results 
provide in vivo evidence that HMGB1 release during I/R is 
mediated, in part, by TLR4 signaling and parallels the extent 
of oxidant production. 
    DISCUSSION   
  Ischemic tissues require mechanisms to notify the immune 
system of the impending cell damage and possible breech of 
  Figure 6.     Antioxidant-mediated hepatic protection during I/R is TLR4 dependent. (A) TLR4 wild-type and mutant mice were used for in vivo study 
of antioxidant effect. Mice were given 300-mg/kg intravenous injections of NAC or control normal saline immediately before ischemia and immediately after 
reperfusion. Mice underwent 1 h of ischemia and 6 h of reperfusion before serum samples were taken and tested for ALT levels. Data represent means   ±   SE 
(  n   = 4  –  6 mice per group). *, P   <   0.05 versus TLR4 wild-type mice that were subjected to I/R and given control normal saline. (B) TLR4 wild-type and mutant 
mice were treated as described for ischemia and were given 1 h of reperfusion. Hepatic tissue was taken and used for approximating the oxidant stress state 
by measuring levels of MDA and 4-HAE, lipid peroxidation by-products produced from oxidant stress. Data represent means   ±   SE (  n   = 4  –  6 mice per group). 
*, P   <   0.05 versus TLR4 wild-type mice that were subjected to I/R and given control normal saline. (C) Hepatic TNF and IL-6 mRNA expression were obtained in 
TLR4 wild-type and mutant mice after ischemia and 6 h of reperfusion. Mice were treated as described with NAC or control normal saline. Results are 
expressed as the relative increase of mRNA expression compared with sham animals. Data represent means   ±   SE (  n   = 4  –  6 mice per group). *, P   <   0.05 versus 
TLR4 wild-type mice that were subjected to I/R and given control normal saline. (D) Serum samples from mice subjected to ischemia and 6 h of reperfusion 
underwent Western blot analysis for HMGB1. Each lane represents a different animal. The blot shown is representative of two experiments with similar results.     2920 HYPOXIA-INDUCED HMGB1 RELEASE IN HEPATOCYTES | Tsung et al.
99%, and we have previously shown that hepatocytes express a 
functional TLR4 (  34  ). 
  The capacity of redox stress to mobilize calcium in hepa-
tocytes was recognized more than two decades ago (  37  ); how-
ever, the involvement of CaMKs in I/R injury has not been 
previously shown. CaMKs are a family of proteins composed 
of CaMK I  –  IV, myosin light chain kinase, and phosphorylase 
kinase (  38, 39  ). Activation typically requires Ca  –  calmodulin 
binding and can be augmented or sustained by phosphoryla-
tion. H  2  O  2   treatment has been shown to activate CaMKs II 
and IV in Jurkat T cells (  40  ), and redox activation of CaMKs may 
occur through both calcium-dependent and -independent 
pathways (  41  ). Our observation that calcium chelation abro-
gates hypoxia-induced HMGB1 release suggests that calcium-
dependent CaMK activity is required. The specifi  c CaMK 
family members involved in hypoxia-induced HMGB1 re-
lease is uncertain, and we show that hepatocytes express CaMKs 
I, II, and IV. Based on experiments in other cells, it is possible 
that more than one isoform could be involved. 
  The downstream targets for CaMK in triggering HMGB1 
release are not known. The greater accumulation of HMGB1 in 
the cytosolic compartment in the presence of CaMK inhibi-
tors during I/R suggests that HMGB1 secretion and not nu-
clear mobilization is the process regulated by CaMK activity. 
Whether CaMKs directly modify HMGB1 is uncertain. 
  Models of organ I/R have revealed unique insights into 
how tissues respond to ischemic stress to activate the resident 
cells of the innate immune system. That the pattern recogni-
tion receptors involved in the recognition of pathogens are 
also used to activate innate immune pathways in response to 
ischemia or tissue damage is now clear. From this and previous 
studies, it is important to appreciate that TLR4-dependent 
signaling is among the most proximal events in I/R-induced 
infl  ammation and may occur in response to ischemia alone to 
trigger downstream signaling events. CaMKs now enter the 
equation as a potential therapeutic target in acute ischemic 
events, along with TLR4 and HMGB1. A recent study also 
points to the importance of resident NKT cells in the early 
infl  ammatory response after I/R (  42  ). Whether NKT cell 
involvement is dependent on TLR4 signaling is not yet 
known; however, the central role of nonparenchymal cells and, 
more specifi  cally, immature dendritic cells (  43  ) in the TLR4-
dependent responses seems more certain. A scheme whereby 
I/R induces infl  ammation through the activation of TLR4 
signaling by an endogenously released cell constituent sup-
ports tenants of the   “  Danger Theory  ”   initially proposed by 
Matzinger (  44, 45  ). 
  MATERIALS AND METHODS 
  Materials.     HMGB1 polyclonal antibody was obtained from New Zealand 
white rabbits immunized with the peptide sequence KSEAGKKGPGRPTGS, 
corresponding to amino acids 166  –  181 of HMGB1. The affi   nity purifi  cation 
of the polyclonal anti-HMGB1 antibody was performed according to stan-
dard procedures (antibody provided by M.T. Lotze, University of Pittsburgh 
Medical Center, Pittsburgh, PA). KN62, KN92, KN93, A23187, and Bapta 
were obtained from EMD. All other chemicals and reagents were obtained 
from Sigma-Aldrich, except where noted. 
lethality in sepsis models (  16, 17, 29  ). Ample evidence now 
exists to indicate the HMGB1 also acts as an early infl  ammatory 
mediator in ischemia (  2, 7  –  9  ), hemorrhagic shock (  10  ), non-
infectious hepatitis (  19  ), and peripheral tissue trauma (unpub-
lished data). Both passive (  19  ) and active (  30, 31  ) pathways for 
HMGB1 release have been described. The passive pathway 
requires the loss of cell membrane integrity, as seen in necrosis. 
The active pathway, best described in LPS- or TNF-stimulated 
macrophage cell lines (  30  ) and cytokine-treated enterocyte 
cell lines (  32  ), appears to involve HMGB1 hyperacetylation 
and packaging into secretory vesicles, at least for enterocytes. 
Recent evidence suggests that phosphorylation on serine resi-
dues within the two nuclear localization sequences prevents 
return of the mobilized HMGB1 to the nucleus (  31  ). We pos-
tulated that the initial HMGB1 release in ischemia would be an 
active process triggered by redox signaling. Indeed, antioxi-
dants prevented HMGB1 release in hypoxic hepatocytes in vitro 
and systemic release of HMGB1 in liver I/R. 250  –  500      M 
H  2  O  2   also induced hepatocyte HMGB1 release without caus-
ing measurable cell death. Interestingly, exogenous H  2  O  2   was 
also recently shown to induce HMGB1 release from a macro-
phage cell line in the absence of cell death (  33  ). Not previously 
shown was the requirement for intact TLR4 signaling for hy-
poxia-induced ROS production and HMGB1 release, as well 
as the involvement of CaMK signaling in HMGB1 release. 
  TLR4 has been shown to be involved in I/R-induced 
infl  ammation in several organs in addition to the liver (  8, 9  ). 
The only molecule known to stimulate TLR4 signaling shown 
to be involved in I/R-induced injury is HMGB1 (  2  ). We pre-
viously reported that hepatocytes express functional TLR4 (  34  ). 
Furthermore, others have shown that oxidant stress up-regu-
lates TLR4 expression (  35  ). However, the requirement for in-
tact TLR4 signaling for hypoxia-induced ROS production is 
novel. Whether a TLR4-activating ligand is required for this 
response is unclear. A neutralizing anti-HMGB1 antibody had 
no eff  ect on the production of ROS by hypoxic hepatocytes. 
Therefore, at least the initial signaling is not dependent on the 
release of HMGB1 into the extracellular space. In HEK294 
T cells, TLR4 has been linked to the activation of the NADPH 
oxidase (  36  ). However, the source of the hypoxia-induced 
ROS production is unknown. Some HMGB1 release was ob-
served in the absence of TLR4 signaling. This may be caused by 
production of ROS through other pathways or by the involve-
ment of other signaling events. The suppression of even this 
lower level of HMGB1 release by CaMK inhibitors suggests 
that TLR4 serves primarily to amplify ROS production. This 
reduction but not inhibition of HMGB1 in the absence of 
hepatocyte TLR4 signaling is consistent with our observations in 
TLR4 chimeric mice where the absence of TLR4 on only pa-
renchymal cells caused only a minor reduction in I/R-induced 
infl  ammatory signaling compared with the reduction seen in 
an absence of TLR4 signaling on nonparenchymal cells (  20  ). 
The possibility that even very low levels (  <  1%) of contaminat-
ing nonparenchymal cells in our hepatocyte preparation could 
contribute to the ROS generation and HMGB1 release re-
mains a possibility. However, hepatocyte purity exceeded JEM VOL. 204, November 26, 2007 
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AUACAGCUCUGGAUAAGAAUU and (antisense) UUCUUAUC-
CAGAGCUGUAUUU; CaMK IV sequence 1, (sense) GAGAUCCUCUG-
GGCGAUUUUU and (antisense) AAAUCGCCCAGAGGAUCUCUU; 
CaMK IV sequence 2, (sense) UCAAGGAAAUAUUCGAAACUU and 
(antisense) GUUUCGAAUAUUUCCUUGAUU; CaMK IV sequence 3, 
(sense) GGUGCUACAUCCAUUGUGUUU and (antisense) ACACAAUG-
GAUGUAGCACCUU; CaMK IV sequence 4, (sense) GGGAUGAAGU-
GUCUUUAAAUU and (antisense) UUUAAAGACACUUCAUCCCUU; 
CaMKK      sequence 1, (sense) GGGCUCAAGUUGGGCUUAUU and (anti-
sense) UAAGGCCCAACUUGAGCCCUU; CaMKK       sequence 2, (sense) 
GCGUGUGUAUCAUGACAUUUU and (antisense) AAUGUCAUGAU-
ACACACGCUU; CaMKK      sequence 3, (sense) GGAAGUGCCCUGCGA-
CAAGUU and (antisense) CUUGUCGCAGGGCACUUCCUU; CaMKK       
sequence 4, (sense) GGAAGUGCCCGUUCAUUGAUU and (antisense) 
UCAAUGAACGGGCACUUCCUU; CaMKK       sequence 1, (sense) 
GGCUGAGAAUUCAGUCAAAUU and (antisense) UUUGACUGAAU-
UCUCGACCUU; CaMKK       sequence 2, (sense) GGACUCUCAUC-
CUUAAGUAUU and (antisense) UACUUAAGGAUGAGAGUCCUU; 
CaMKK       sequence 3, (sense) GAACGAAUCAUGUGUUUGCUU 
and(antisense) GCAAACACAUGAUUCGUUCUU; and CaMKK       se-
quence 4, (sense) UCACACCACGUCUCCAUUAUU and (antisense) 
UAAUGGAGACGUGGUGUGAUU. 2.5 pmol siRNA was diluted in 
100      l of culture medium without serum. 23      l of Hiperfect transfection 
reagent (QIAGEN) was added to the diluted siRNA and mixed. The trans-
fection mixture was incubated for 10 min at room temperature, then applied to 
each well and incubated for 72 h. Transfection effi   ciency was determined at 
48 h by fl  uorescence microscopy of cells subjected to RNA interference 
(RNAi) with fl  uorescent cyclophilin B siRNA. For each experiment, at least 
three microscopic visual fi  elds (200-fold magnifi  cation) were counted, thereby 
calculating the ratio of fl  uorescent cyclophilin-expressing cells to nonfl  uores-
cent cells. The specifi  city of RNAi was determined by Western blot or RT-
PCR (RT-PCR was performed to confi  rm knockdown of CaMK       because 
there are no commercially available antibodies recognizing this protein). All 
experiments and cell number determinations were performed in triplicate. 
  Determination of ROS.     3   ×   10  6   hepatocytes were plated onto 6-cm gela-
tin-coated plastic tissue culture dishes in Williams  ’   medium E as described in 
Cell culture and treatment. 2 h before the experiment, cells were washed 
with cold KHB (pH 7.4) and incubated in warm KHB (pH 7.4). 30 min be-
fore the start of the experiment, cells were again washed with KHB (pH 7.4) 
and incubated with KHB containing 1      l/ml of a 10-mM DCF diacetate 
(DCF-DA) in DMSO stock solution for a fi  nal concentration of 10      M 
(Invitrogen). After 30 min of incubation, the media was changed to fresh 
KHB (pH 7.4) for normoxia cells or hypoxic KHB (pH 6.2, equilibrated with 
1% O  2  , 5% CO  2  , and 94% N  2  ) and placed into the appropriate incubator. After 
treatment, cells were scraped on ice and lysed with CelLytic M reagent 
(Sigma-Aldrich) followed by centrifugation at 10,000 rpm for 10 min. Super-
natants were read in a fl  uorescence spectrophotometer (SpectraMAX Gemini 
XS; MDS Analytical Technologies) with 485-nm excitation and 530-nm 
emission wavelengths. 
  Liver damage assessment.     To assess hepatic function and cellular injury 
after liver ischemia, sALT levels were measured using a clinical chemistry system 
(opeRA; Bayer Co.). 
  Measurement of lipid peroxidation.     Assessment of the level of oxidative 
stress in the hepatocytes taken from the in vivo experiments was assessed by 
measuring by-products of lipid peroxidation, specifi  cally MDA and 4-HAE. 
This was done according to the protocol described by the Lipid Peroxidation 
Assay Kit (EMD). 
  Confocal immunofl  uorescence imaging.     A segment of the left lobe of the 
liver was fi  xed in 2% paraformaldehyde in PBS overnight and cryoprotected in 
30% sucrose in PBS for another 24 h. Livers were frozen in liquid nitrogen  –
  cooled isopentane. These samples were stored at   −  80  °  C until sectioned. 6-     m 
  Animals.     Male wild-type (C57BL/6, C57BL/10SnJ, and C3H/HeOuj) 
and TLR4-defective (KO, C57BL/10ScCr; mutant, C3H/HeJ) mice (8  –  12 wk 
old) were purchased from the Jackson Laboratory. Male Sprague-Dawley 
rats, also pathogen free, weighing 350  –  400 g were obtained from Charles 
River Laboratories. All animals were maintained in a laminar-fl  ow, specifi  c 
pathogen-free atmosphere at the University of Pittsburgh. Animal protocols 
were approved by the Animal Care and Use Committee of the University of 
Pittsburgh, and the experiments were performed according to the National 
Institutes of Health guidelines for the use of laboratory animals. 
  Liver ischemia.     A previously described I/R protocol involving a nonlethal 
model of segmental (70%) hepatic warm ischemia was used (  2  ). Sham ani-
mals underwent anesthesia, laparotomy, and exposure of the portal triad 
without hepatic ischemia. 
  Experimental design.     For CaMK inhibition studies, mice received 16-mg/kg 
doses of either KN93 (water-soluble inhibitor of CaMK activity) or KN92 
(inactive analogue of KN93) by intraperitoneal injection 12 and 1 h before 
ischemia. Studies involving antioxidants consisted of mice receiving a 300-mg/kg 
dose of NAC by intravenous injection immediately before ischemia and 
immediately after reperfusion. Animals were killed at predetermined time 
points after reperfusion for serum and liver samples. 
  Hepatocyte isolation.     Hepatocytes were isolated from rats and mice by an 
in situ collagenase (type IV; Sigma-Aldrich) perfusion technique, which was 
modifi  ed as previously described (  46  ). Hepatocytes were separated from the 
nonparenchymal cells by two cycles of diff  erential centrifugation (400 rpm 
[50   g  ] for 2 min) and further purifi  ed over a 30% Percoll gradient. Hepatocyte 
purity was   >  98%, as assessed by light microscopy, and viability was typically 
  >  95%, as determined by a Trypan blue exclusion assay. 
  Cell culture and treatment.     3   ×   10  6   hepatocytes were plated onto 6-cm 
gelatin-coated plastic tissue culture dishes. The initial culture medium was 
Williams  ’   medium E containing 10% calf serum, 15 mM Hepes, 2 mM 
  l-  glutamine, and 100 U/ml penicillin and streptomycin. Hepatocytes were al-
lowed to attach to plates overnight. For experiments involving hypoxia, the 
medium was replaced with hypoxic medium (equilibrated with 1% O  2  , 5% 
CO  2  , and 94% N  2  ) and placed into a modular incubator chamber (Billups-
Rothenberg), which was fl  ushed with the same hypoxic gas mixture. The 
cells were exposed to hypoxia for various time points for determination of 
ROS production or HMGB1 release in the supernatants. In TLR4 transfec-
tion experiments, hepatocytes were transfected with recombinant adeno-
virus encoding mouse TLR4 (Ad-TLR4) or empty adenoviral vector control 
(Ad-null), prepared as previously described (  34  ), and subjected to hypoxia 
for ROS analysis. For H  2  O  2   studies, 4   ×   10  5   hepatocytes per well were plated 
on sixwell plates and allowed to attach to the plates overnight. The media 
was replaced before stimulation of the cells with the appropriate amount of 
H  2  O  2   and incubated at 37  °  C for the times indicated in the fi  gures. Where 
applicable, hepatocytes treated with NAC or trolox were allowed to incubate 
for 30 min with H  2  O  2   before antioxidant treatment. 
  Transfection of fl  uorescein-labeled cyclophilin, CaMKK     , CaMKK     , 
CaMK I, CaMK IV, and CaMK II     siRNA.     Murine hepatocytes at a 
concentration of 1.5   ×   10  5   were seeded in each well of a 24-well plate in 1 ml 
of culture medium to yield a confl  uence of     80%. Hepatocytes were allowed 
to adhere for 4 h. Before transfection, the medium was exchanged for 500      l per 
well of culture medium without antibiotics. Fluorescein-labeled cyclophilin, 
CaMK I, CaMK IV, CaMKK      , CaMKK      , and CaMK II      siRNA were 
obtained (Dharmacon) that incorporate four siRNAs into one siRNA pool. 
The sequences used for each target were as follows: CaMK I sequence 1, 
(sense) GAACGAGAUUGCCGUCUUAUU and (antisense) UAAGACGG-
CAAUCUCGUUCUU; CaMK I sequence 2, (sense) CGGAAGACAUUA-
GGGAUAUUU and (antisense) AUAUCCCUAAUGUCUUCCGUU; 
CaMK I sequence 3, (sense) GGAGAGCUGUUUGACCAGGUU and (anti-
sense) UUCGGUCAAACAGCUCUCCUU; CaMK I sequence 4, (sense) 2922 HYPOXIA-INDUCED HMGB1 RELEASE IN HEPATOCYTES | Tsung et al.
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sections were washed three times with PBS and blocked with 2% BSA in PBS 
for 45 min, followed by three washes with 0.5% BSA in PBS. This was followed 
by anti-HMGB1 antibody (1:1,000 in 0.5% BSA) for 60 min at room temper-
ature. The slides were washed with 0.5% BSA, and a secondary antibody (goat 
anti  –  rabbit Alexa Fluor 488, 1:500 in 0.5% BSA; Invitrogen) was applied 
with F-actin counterstain (rhodamine phalloidin, 1:250 in PBS; Invitrogen) 
for another 60 min. The slides were rinsed and HOECHST dye (1 mg/100 ml 
bisbenzimide) was applied for 30 s. The slides were rinsed with PBS and cover-
slipped with gelvatol, a water-soluble mounting media (21 g polyvinylalcohol, 
52 ml water, sodium azide, 106 ml 0.2-M Tris buff  er). Slides were visualized 
with a confocal microscope (Fluoview 1000; Olympus). 
  Sodium dodecyl sulfate/polyacrylamide gel electrophoresis and 
Western blotting.     Western blot analysis for HMGB1 was as follows. Pri-
mary polyclonal rabbit antibody to HMGB1 (1:1,000) was used for Western 
blotting. Membranes were developed with the Super Signal West Pico chemilu-
minescent kit (Thermo Fisher Scientifi  c) and exposed to fi  lm. 
  SYBR green real-time RT-PCR.     Total RNA was extracted from the liver 
using the TRI  zol   reagent (Invitrogen) according to the manufacturer  ’  s in-
structions. mRNA for TNF-     , IL-6, and GAPDH was quantifi  ed in duplicate 
by SYBR green two-step, real-time RT-PCR. After removal of potentially 
contaminating DNA with DNase I (Invitrogen), 1   μ  g of total RNA from each 
sample was used for reverse transcription with oligo dT (Invitrogen) and 
Superscript II (Invitrogen) to generate fi  rst-strand cDNA. The PCR reaction 
mixture was prepared using SYBR green PCR Master Mix (Applied Bio-
systems) using previously described primers (  47, 48  ). Thermal cycling conditions 
were 10 min at 95  °  C, followed by 40 cycles of 95  °  C for 15 s and 60  °  C for 1 min 
on a sequence detection system (ABI PRISM 7000; Applied Biosystems). 
Each gene expression was normalized with GAPDH mRNA content. 
  Statistical analysis.     Results are expressed as the mean   ±   SEM. Group 
comparisons were performed using the Student  ’  s   t   test or analysis of variance. 
Diff  erences were considered signifi  cant at P   <   0.05. 
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